PULMONX CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
PULMONX CORPORATION (LUNG) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 457.70 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-04
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 86.65K shares, a 4714.11% increase year-over-year.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 371.05K shares, a 1306.82% increase year-over-year.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 515.30K shares, a 635.89% increase year-over-year.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 543.48K shares, a 61.90% increase from fiscal 2024.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 335.68K shares, a 570.76% increase from fiscal 2023.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 50.05K shares, a 57.60% decline from fiscal 2022.
- PULMONX CORPORATION share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 118.04K shares, a 11.85% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 86.65K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 457.70K shares 10-Q · filed 2026-08-04 | 973.01K shares derived: sum of 3 quarters · filed 2026-08-04 | 973.01K shares derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | 371.05K shares 10-Q · filed 2026-05-04 | 886.35K shares derived: sum of 2 quarters · filed 2026-05-04 | 886.35K shares derived: sum of 3 quarters · filed 2026-05-04 | 888.15K shares derived: sum of 4 quarters · filed 2026-05-04 |
| 2025-12-31 | 515.30K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 515.30K shares derived: sum of 2 quarters · filed 2026-03-10 | 517.10K shares derived: sum of 3 quarters · filed 2026-03-10 | 543.48K shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 1.80K shares derived: sum of 2 quarters · filed 2025-11-12 | 28.18K shares 10-Q · filed 2025-11-12 | 98.20K shares derived: sum of 4 quarters · filed 2026-03-10 |
| 2025-06-30 | 1.80K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | 28.18K shares 10-Q · filed 2025-08-01 | 98.20K shares derived: sum of 3 quarters · filed 2026-03-10 | 131.62K shares derived: sum of 4 quarters · filed 2026-03-10 |
| 2025-03-31 | 26.38K shares 10-Q · filed 2025-05-02 | 96.40K shares derived: sum of 2 quarters · filed 2026-03-10 | 129.82K shares derived: sum of 3 quarters · filed 2026-03-10 | 235.73K shares derived: sum of 4 quarters · filed 2026-03-10 |
| 2024-12-31 | 70.02K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 103.44K shares derived: sum of 2 quarters · filed 2026-03-10 | 209.35K shares derived: sum of 3 quarters · filed 2026-03-10 | 335.68K shares 10-K · filed 2026-03-10 |
| 2024-09-30 | 33.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-01 | 139.33K shares derived: sum of 2 quarters · filed 2024-11-01 | 265.66K shares 10-Q · filed 2024-11-01 | 268.86K shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2024-06-30 | 105.91K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | 232.24K shares 10-Q · filed 2024-08-02 | 235.44K shares derived: sum of 3 quarters · filed 2025-02-25 | 239.78K shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2024-03-31 | 126.33K shares 10-Q · filed 2024-05-03 | 129.53K shares derived: sum of 2 quarters · filed 2025-02-25 | 133.87K shares derived: sum of 3 quarters · filed 2025-02-25 | 147.37K shares derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-12-31 | 3.20K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | 7.54K shares derived: sum of 2 quarters · filed 2025-02-25 | 21.04K shares derived: sum of 3 quarters · filed 2025-02-25 | 50.05K shares 10-K · filed 2025-02-25 |
| 2023-09-30 | 4.34K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | 17.84K shares derived: sum of 2 quarters · filed 2023-11-03 | 46.84K shares 10-Q · filed 2023-11-03 | 71.23K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-06-30 | 13.50K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | 42.51K shares 10-Q · filed 2023-08-04 | 66.89K shares derived: sum of 3 quarters · filed 2024-02-27 | 133.34K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-03-31 | 29.01K shares 10-Q · filed 2023-05-08 | 53.39K shares derived: sum of 2 quarters · filed 2024-02-27 | 119.84K shares derived: sum of 3 quarters · filed 2024-02-27 | 133.01K shares derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-12-31 | 24.38K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | 90.83K shares derived: sum of 2 quarters · filed 2024-02-27 | 104.00K shares derived: sum of 3 quarters · filed 2024-02-27 | 118.04K shares 10-K · filed 2024-02-27 |
| 2022-09-30 | 66.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 79.62K shares derived: sum of 2 quarters · filed 2022-11-08 | 93.66K shares 10-Q · filed 2022-11-08 | 113.51K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-06-30 | 13.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 27.21K shares 10-Q · filed 2022-08-08 | 47.06K shares derived: sum of 3 quarters · filed 2023-03-01 | 76.34K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2022-03-31 | 14.04K shares 10-Q · filed 2022-05-09 | 33.89K shares derived: sum of 2 quarters · filed 2023-03-01 | 63.17K shares derived: sum of 3 quarters · filed 2023-03-01 | 97.96K shares derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-12-31 | 19.85K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | 49.13K shares derived: sum of 2 quarters · filed 2023-03-01 | 83.92K shares derived: sum of 3 quarters · filed 2023-03-01 | 133.91K shares 10-K · filed 2023-03-01 |
| 2021-09-30 | 29.28K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 64.07K shares derived: sum of 2 quarters · filed 2021-11-09 | 114.05K shares 10-Q · filed 2021-11-09 | 147.96K shares derived: sum of 4 quarters · filed 2022-03-01 |
| 2021-06-30 | 34.79K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | 84.77K shares 10-Q · filed 2021-08-10 | 118.68K shares derived: sum of 3 quarters · filed 2022-03-01 | |
| 2021-03-31 | 49.98K shares 10-Q · filed 2021-05-12 | 83.89K shares derived: sum of 2 quarters · filed 2022-03-01 | ||
| 2020-12-31 | 33.91K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 76.95K shares 10-K · filed 2022-03-01 | ||
| 2020-09-30 | 43.04K shares 10-Q · filed 2020-11-13 | |||
| 2019-12-31 | 35.81K shares 10-K · filed 2021-03-15 | |||
| 2018-12-31 | 31.20K shares 10-K · filed 2021-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |